Besides, the authors revealed that m6A reader IGF2BP3 maybe a potential oncogene for Clear cell renal cell carcinoma (ccRCC), even though they cannot reliably predict the prognosis of ccRCC patients based on the risk score according to the mRNA expression of m6A regulatory genes. Here, IGF2BP3 is linked to nonpapillary renal cell carcinoma.